Yasuo Takamune

Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

Yoshihiro Yoshitake, Daiki Fukuma, Akira Yuno et al. · Clinical Cancer Research · 2014 · 153 citations · Full text

Medicine, Immunology, Oncology +17

ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma

Yasuo Takamune, Tetsuro Ikebe, Osamu Nagano et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2006 · 38 citations

Medicine, Cancer Biology, Oncology +11

Involvement of NF-κB-mediated maturation of ADAM-17 in the invasion of oral squamous cell carcinoma

Yasuo Takamune, Tetsuro Ikebe, Osamu Nagano et al. · Biochemical and Biophysical Research Communications · 2007 · 33 citations

Medicine, Cancer Biology, Oncology +10

Selective inhibition of nuclear factor‐κB by nuclear factor‐κB essential modulator‐binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma

Takuya Tanaka, Hideki Nakayama, Yoshihiro Yoshitake et al. · Cancer Science · 2011 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +17

A low dicer expression is associated with resistance to 5‐<scp>FU</scp>‐based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma

Kenta Kawahara, Hideki Nakayama, Masashi Nagata et al. · Journal of Oral Pathology and Medicine · 2013 · 23 citations

Medicine, Cancer Biology, Oncology +17